MOUNTAIN VIEW, Calif. — DNAnexus Inc., the leader in cloud-based genome informatics and data management, today announced that POLARIS (Personalized OMIC Lattice for Advanced Research and Improving Stratification), is now using DNAnexus to enable a series of genomic tests. The production-scale clinical applications will be used by the Genome Institute of Singapore (GIS). POLARIS was […]
Germantown, Maryland, and Hilden, Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it had reached a milestone in its portfolio of master collaboration agreements with leading pharmaceutical companies and a record number of new projects in 2015 for the co-development of companion diagnostics. Among the record number of new projects was […]
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced that it has moved to simplify and strengthen its capital structure by entering into a conversion agreement with the holders of its outstanding Series A and Series B convertible preferred […]
SAN DIEGO, Calif. — Agena Bioscience today announced the expansion of its headquarters to a new site in San Diego. Located at 4755 Eastgate Mall, the new 55,000-square-foot facility houses the company’s laboratory, manufacturing, and office workforce. “We’re tremendously excited about moving our headquarters into a larger space. Not only will the new facility enable […]
OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing precision medicine through advanced diagnostic tests and clinical and research services, today announced that it raised gross proceeds of approximately $2.2 million in a preferred stock and warrant private placement financing with existing investors Crede Capital Group, LLC and Third Security, LLC. Through […]
SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today provided preliminary operational and financial results for the year endedDecember 31, 2015. Financial Highlights: Total revenue for 2015 expected to be in the range of $61.5 to $62.5 million, representing an increase of 29% to […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced GRAIL, a new company formed to enable cancer screening from a simple blood test. Powered by Illumina sequencing technology, GRAIL will develop a pan-cancer screening test by directly measuring circulating nucleic acids in blood. Detecting cancer at the earliest stages dramatically increases long-term survival, hence the successful […]
WALTHAM, Mass. and SANTA CLARA, Calif.– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Affymetrix Inc. (NASDAQ: AFFX), a leading provider of cellular and genetic analysis products, today announced that their boards of directors have unanimously approved Thermo Fisher’s acquisition of Affymetrix for $14.00 per share in cash. The transaction […]
PierianDx, the leading provider of genomic software and services to enable data-driven personalized medicine, announced that it closed $9.25 million in Series A financing led by New York-based Health Catalyst Capital Management (HCCM). Joining HCCM in the investment round is a venture investing affiliate of Ocean Road Advisors, Inova Translational Medicine Institute (ITMI), and ARUP […]
SAN FRANCISCO, CA and SEATTLE, WA – Medivation, Inc. (NASDAQ: MDVN) and NanoString Technologies, Inc., (NASDAQ: NSTG) today announced they have entered into a collaboration, together with Astellas Pharma Inc., to pursue the translation of a novel gene expression signature algorithm from Medivation into a companion diagnostic assay using NanoString’s nCounter® Dx Analysis System. Under […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
